Lyfe Rx Tirzepatide Review: Price, Refund Fees and FDA History
Researched & written by Alan PierceClinical Pharmacology WriterUpdated
FDA warning letter
FDA issued Lyfe Rx a warning letter in September 2025 (Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)). Read the letter on FDA’s own warning-letter database.
On this page
Lyfe Rx identifies compounded tirzepatide with an embedded catalog amount; selected supply and payment terms require confirmation.
Standout details
- Names compounded tirzepatide in current product information
- Describes consultation, supplies, overnight shipping and messaging within the offer
Things to consider
- $399 catalog value does not establish a monthly bill or supply duration
- Official refund pages conflict: $50 versus $40 consultation plus $70 live-visit fee when applicable
Lyfe Rx's current product page identifies a compounded GIP/GLP-1 containing tirzepatide. Its embedded product and variant data list $399, but that catalog amount does not establish a selected supply duration or recurring total. The page says membership and a multi-month agreement are not required and subscription is optional. Confirm the purchase type and itemized prescription before authorizing payment.3
The catalog price is not the whole contract
The product describes medication, provider consultation, injection supplies, overnight shipping and follow-up messaging as included. Embedded purchase-plan data also contain a discounted subscription amount; no selected discount eligibility, billing interval or usable supply was verified. Compare the actual total and next charge, not an assumed $399 monthly subscription.3
General terms describe automatic renewal for subscription purchases until cancellation through the account's Subscriptions section and allow taxes or shipping where applicable. An intake is required after checkout, and a provider must approve treatment before fulfillment. A product-page no-membership message does not eliminate recurring charges if a subscription is selected.4
| Topic | What to know |
|---|---|
| Named product | Compounded GIP/GLP-1 containing tirzepatide |
| Catalog data | $399 product amount; selected duration unverified |
| Purchase choice | Subscription optional; confirm actual next charge |
| Inclusions | Medication, consultation, supplies, shipping and messaging described |
Refund fees conflict across official pages
The dedicated cancellation page permits a refund before a prescription is filled, less a $50 medical-intake and doctor fee. The separate store refund policy instead lists a $40 standard consultation fee plus a $70 live-visit fee if applicable, with no guarantee of cancellation once the prescription reaches the pharmacy. Both make filled or shipped medication generally final. Do not assume one fee schedule supersedes the other without written confirmation.5,6
The product page says nonapproval results in a refund less an administrative fee but does not give that amount. The store policy also contains broad language making service fees and prepaid plans nonrefundable. Ask which agreement governs the selected order, the retained amount if not approved, and the exact filling cutoff. Canceling a future subscription and refunding the current prescription are separate requests.3,5,6
The store policy asks for 48 hours' notice for appointment changes; that is not a verified subscription-renewal deadline. It discusses defective-product review but does not support an unconditional cash refund or replacement promise for every shipping issue. Retain the written response and contact support promptly if a delivery is wrong or damaged.6
| Topic | What to know |
|---|---|
| Dedicated policy | Before filling, less $50 fee |
| Store policy | $40 consultation plus $70 live visit if applicable; conditions differ |
| Filled or shipped | Generally final; confirm exact cancellation stage |
| FDA history | September 9, 2025 misleading-marketing letter; current resolution unverified |
What the FDA letter actually says
FDA issued Lyfe Rx a warning letter dated September 9, 2025, after reviewing its website in August 2025. The letter concerns false or misleading efficacy claims for compounded semaglutide and tirzepatide, including implications that the products were the same as FDA-approved drugs. This is a specific historical marketing/misbranding action. It does not establish the company's current response, that every current product violates the law, or a current closure or safety determination.7
The current product page acknowledges that compounded medication is not FDA-approved or equivalent to a branded product. That wording is relevant but does not by itself prove FDA accepted a response or closed the matter. The original brand-drug trial references likewise do not validate a particular compounded batch or Lyfe Rx patient results.1,2,3,7
Confirm accountable care before payment
The retrieved pages describe provider review and independent U.S. pharmacy fulfillment, but do not establish the legal practice or specific pharmacy facility assigned to this order. Obtain those names, your state eligibility, formulation, quantity and follow-up arrangement. A displayed certification claim or generic pharmacy assurance is not independent current credential verification. Weigh the historical regulatory issue and unresolved fee conflict alongside the complete prescription quote.
Further reading
Compounded Tirzepatide Legal Status, Zepbound Side Effects, Tirzepatide Gallbladder, Tirzepatide Thyroid Cancer Warning, Tirzepatide Evidence Guide, Luvo Health Review, Coreage Rx Review, Best/Tirzepatide.
Frequently asked questions
Is Lyfe Rx tirzepatide $399 monthly?
Current embedded product data list $399, but a selected supply duration or recurring total was not verified. The page says subscription is optional; confirm the actual dose, quantity and purchase plan.
What is retained if I cancel before filling?
The dedicated policy says $50, while the store policy lists $40 consultation plus a $70 live-visit fee if applicable. Obtain the governing fee schedule and exact filling cutoff before payment.
What did FDA warn Lyfe Rx about?
The September 9, 2025 letter concerns false or misleading claims for compounded semaglutide and tirzepatide. It is historical regulatory context; current resolution or closure was not established.
References(7)
- Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. Read source
- Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. Read source
- Lyfe Rx (2026). Compounded GIP/GLP-1 product and embedded variant data. Lyfe Rx.
- Lyfe Rx (2026). Terms and conditions. Lyfe Rx.
- Lyfe Rx (2026). Dedicated cancellation and refund policy. Lyfe Rx.
- Lyfe Rx (2026). Store refund policy. Lyfe Rx.
- U.S. Food and Drug Administration (2025). Lyfe Rx warning letter, September 9, 2025. FDA. Read source
About the author
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Continue reading
Browse provider reviewsLuvo Health Tirzepatide Review: Four-Week Pricing and Refunds
Luvo Health review: $124.50 introductory compounded tirzepatide, $249 per four weeks afterward, and important differences between checkout and refund terms.
ReadCoreAge Rx Tirzepatide Review: Price, Renewals and Refund Limits
CoreAge Rx’s $129 starting offer, unconfirmed selected supply, consultation-fee differences, 30-day order finality and cancellation before renewal processing.
ReadIs Compounded Tirzepatide Still Legal in 2026?
Tirzepatide's shortage ended in 2024 and FDA's compounding grace period closed in early 2025. Here's the precise legal status of compounded tirzepatide in 2026.
ReadZepbound Side Effects: Full Breakdown by Frequency
Compare common Zepbound side effects by dose, see trial frequencies and learn which warning signs need prompt medical attention.
ReadTirzepatide and Gallbladder Problems
How often tirzepatide causes gallstones and cholecystitis, why rapid weight loss is part of it, and the red-flag symptoms that need urgent care.
ReadTirzepatide Thyroid Cancer Warning Explained
What tirzepatide's boxed thyroid C-cell tumor warning actually means: verbatim FDA label text, the rat data behind it, and what human evidence shows.
Read